Concussions Market Size, Share & Trends Analysis Report by Drug Class, Region, and Competitive Landscape - ResearchAndMarkets.com

The global concussions market is expected to grow due to increased awareness of concussion risks, particularly in sports and military sectors, and the adoption of innovative diagnostic tools and treatment options. North America holds the highest market share, driven by advanced healthcare infrastructure and strong regulatory support. Pain relief medications hold the highest market share, with the demand driven by the increasing participation in contact sports and the high prevalence of concussions among military personnel. Key players include Oragenics, Oxeia Biopharmaceuticals, American CryoStem, Astrocyte, NeuroVive, Neuren, KineMed, Novartis, Pfizer, and Sanofi.